Prospective Observational Study to Assess Effectiveness of Intravitreal Aflibercept in Patients With Wet Macular Degeneration in Greece

CompletedOBSERVATIONAL

Enrollment

119

Participants

Timeline

Start Date

July 1, 2016

Primary Completion Date

July 10, 2019

Study Completion Date

December 13, 2019

Conditions

Choroidal NeovascularizationMacular Degeneration

Interventions

DRUG

Aflibercept (Eylea, BAY86-5321)

Intravitreal injection; should comply with the recommendations written in the local Summary of Product Characteristics (SPC) of the product

Trial Locations (1)

Many Locations, Multiple Locations